SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-21-022624
Filing Date
2021-01-29
Accepted
2021-01-29 16:12:03
Documents
119
Period of Report
2021-01-29

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d105069d6k.htm 6-K 13404
2 EX-99.1 d105069dex991.htm EX-99.1 753368
9 GRAPHIC g105069g58u78.jpg GRAPHIC 94157
  Complete submission text file 0001193125-21-022624.txt   9361534

Data Files

Seq Description Document Type Size
3 XBRL INSTANCE DOCUMENT asln-20210930.xml EX-101.INS 2846489
4 XBRL TAXONOMY EXTENSION SCHEMA asln-20210930.xsd EX-101.SCH 106370
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE asln-20210930_cal.xml EX-101.CAL 51005
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE asln-20210930_def.xml EX-101.DEF 296790
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE asln-20210930_lab.xml EX-101.LAB 573600
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE asln-20210930_pre.xml EX-101.PRE 481799
Mailing Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920
Business Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920 65 6222 4235
ASLAN Pharmaceuticals Ltd (Filer) CIK: 0001722926 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38475 | Film No.: 21571306
SIC: 2834 Pharmaceutical Preparations